T. Nakagawa et al., Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma, INT J ONCOL, 14(2), 1999, pp. 281-286
Protein induced vitamin K absence or antagonist II (PIVKA-II) and alpha-fet
oprotein (AFP) have been considered useful serum markers of hepatocellular
carcinoma (HCC). In this study, we examined the clinicopathologic significa
nce of these tumour markers in patients with HCCs by measuring their serum
levels and performing immunohistochemistry. We studied 349 Japanese patient
s with HCCs. Their serum PIVKA-II and AFP levels were determined by enzyme
immunoassay before treatment. We examined the correlations between serum PI
VKA-II and AFP levels and tumour size, presence of satellite nodules, histo
logic HCC grade, and concomitant liver diseases and subjected tumour tissue
s to immunohistochemical staining to detect PIVKA-II and AFP expression. Th
e serum PIVKA-II levels of patients with poorly differentiated HCCs were si
gnificantly higher than those of patients with well and moderately differen
tiated HCCs (p<0.05) and they were higher in HCC patients with than without
satellite nodules. The serum AFP levels were influenced significantly by c
oncomitant liver diseases, but not by the other factors. Immunohistochemica
l staining revealed the PIVKA-II expression levels of poorly differentiated
HCCs were higher than those of well and moderately differentiated HCCs (p<
0.05). Some HCC cells were PIVKA-II-positive, others were AFP-positive, and
some expressed both. The serum PIVKA-II concentration was a better indicat
or of HCC than AFP, as it was not influenced by concomitant liver diseases.
The presence of PIVKA-II in serum correlated with the presence of satellit
e nodules and the histologic HCC grade, a result concordant with the immuno
histochemical findings.